These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 22397292

  • 1. [Evaluation of coagulation factors in fresh frozen plasma treated with riboflavin and ultraviolet light].
    Antić A, Stanojković Z, Macukanović-Golubović L, Jelić M.
    Vojnosanit Pregl; 2012 Jan; 69(1):22-6. PubMed ID: 22397292
    [Abstract] [Full Text] [Related]

  • 2. [Pathogen inactivation in fresh frozen plasma using riboflavin and ultraviolet light: effects on plasma proteins and coagulation factor VII].
    Stanojković Z, Antić A.
    Vojnosanit Pregl; 2011 Jan; 68(1):51-6. PubMed ID: 21425619
    [Abstract] [Full Text] [Related]

  • 3. [Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentrates].
    Stanojković Z, Antić A, Stojanović M.
    Vojnosanit Pregl; 2011 Jun; 68(6):489-94. PubMed ID: 21818915
    [Abstract] [Full Text] [Related]

  • 4. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
    Hornsey VS, Drummond O, Morrison A, McMillan L, MacGregor IR, Prowse CV.
    Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
    [Abstract] [Full Text] [Related]

  • 5. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
    Ettinger A, Miklauz MM, Hendrix BK, Bihm DJ, Maldonado-Codina G, Goodrich RP.
    Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884
    [Abstract] [Full Text] [Related]

  • 6. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ, Ettinger A, Buytaert-Hoefen KA, Hendrix BK, Maldonado-Codina G, Rock G, Giclas PC, Goodrich RP.
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [Abstract] [Full Text] [Related]

  • 7. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J, Rock G.
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [Abstract] [Full Text] [Related]

  • 8. Plasma constituent integrity in pre-storage vs. post-storage riboflavin and UV-light treatment--a comparative study.
    Balint B, Jovicic-Gojkov D, Todorovic-Balint M, Subota V, Pavlovic M, Goodrich R.
    Transfus Apher Sci; 2013 Dec; 49(3):434-9. PubMed ID: 23820430
    [Abstract] [Full Text] [Related]

  • 9. The influence of riboflavin photochemistry on plasma coagulation factors.
    Larrea L, Calabuig M, Roldán V, Rivera J, Tsai HM, Vicente V, Roig R.
    Transfus Apher Sci; 2009 Dec; 41(3):199-204. PubMed ID: 19782644
    [Abstract] [Full Text] [Related]

  • 10. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
    Feys HB, Van Aelst B, Devreese K, Devloo R, Coene J, Vandekerckhove P, Compernolle V.
    Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
    [Abstract] [Full Text] [Related]

  • 11. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P, Culibrk B, Karwal S, Serrano K, Levin E, Bu D, Bhakta V, Sheffield WP, Goodrich RP, Devine DV.
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [Abstract] [Full Text] [Related]

  • 12. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD, Saakadze N, Bowen R, Newman JL, Karatela S, Gordy P, Marschner S, Roback J, Hillyer CD.
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [Abstract] [Full Text] [Related]

  • 13. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R.
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [Abstract] [Full Text] [Related]

  • 14. Quality of proteins in riboflavin and UV light-treated FFP during 1 year of storage at -18°C.
    Ettinger A, Miklauz MM, Hendrix BK, Bihm DJ, Maldonado-Codina G, Goodrich RP.
    Transfus Apher Sci; 2012 Feb; 46(1):15-8. PubMed ID: 22115607
    [Abstract] [Full Text] [Related]

  • 15. The effectiveness of riboflavin photochemical-mediated virus inactivation and changes in protein retention in fresh-frozen plasma treated using a flow-based treatment device.
    Zhu L, Pan J, Wei C, Wang H, Xiang R, Zhang J, Wang D.
    Transfusion; 2015 Jan; 55(1):100-7. PubMed ID: 25070346
    [Abstract] [Full Text] [Related]

  • 16. Preparation of cryoprecipitate from riboflavin and UV light-treated plasma.
    Ettinger A, Miklauz MM, Bihm DJ, Maldonado-Codina G, Goodrich RP.
    Transfus Apher Sci; 2012 Apr; 46(2):153-8. PubMed ID: 22342281
    [Abstract] [Full Text] [Related]

  • 17. Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants.
    Aznar JA, Bonanad S, Montoro JM, Hurtado C, Cid AR, Soler MA, De Miguel A.
    Vox Sang; 2000 Apr; 79(3):156-60. PubMed ID: 11111234
    [Abstract] [Full Text] [Related]

  • 18. Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification.
    Stanojkovic Z, Balint B, Antic A, Todorovic M, Ostojic G, Pavlovic M.
    Transfus Apher Sci; 2012 Aug; 47(1):33-7. PubMed ID: 22465578
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of riboflavin and ultraviolet light treatment against Klebsiella pneumoniae in whole blood-derived platelets: A pilot study.
    Alabdullatif M, Osman IE, Alrasheed M, Ramirez-Arcos S, Alyousef M, Althawadi S, Alhumiadan H.
    Transfusion; 2021 May; 61(5):1562-1569. PubMed ID: 33687079
    [Abstract] [Full Text] [Related]

  • 20. Study of coagulation function in thawed apheresis plasma for photochemical treatment by amotosalen and UVA.
    de Valensart N, Rapaille A, Goossenaerts E, Sondag-Thull D, Deneys V.
    Vox Sang; 2009 Apr; 96(3):213-8. PubMed ID: 19207170
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.